Who
Kristopher Hanson
General Counsel
Company insider
Files Form 4 as: General Counsel, MapLight Therapeutics; SVP and General Counsel, PhaseBio Pharmaceuticals.
In numbers
- Trades disclosed
- 60
- Buys
- 0
- Sells
- 9
- Bought
- $0
- Sold
- $3.4M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 7 Oct 2019
- Last trade
- 15 Oct 2026
- Last filed
- 16 Oct 2026
Companies traded
Activity over time
1 Apr – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Oct 2026filed 16 Oct 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $73K9,020 at $8.08 | filing |
| 16 Sep 2026filed 18 Sep 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $193K16,509 at $11.67 | filing |
| 16 Sep 2026filed 18 Sep 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $193K16,509 at $11.67 | filing |
| 17 Aug 2026filed 19 Aug 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Code A | —7,730 at $0.00 | filing |
| 17 Aug 2026filed 19 Aug 2026 | MPLT MapLight Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —31,395 at $0.00 | filing |
| 17 Aug 2026filed 19 Aug 2026 | MPLT MapLight Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —31,395 at $0.00 | filing |
| 17 Aug 2026filed 19 Aug 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Code A | —7,730 at $0.00 | filing |
| 17 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $43K1,130 at $37.90 | filing |
| 17 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $43K1,130 at $37.90 | filing |
| 16 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $174K4,776 at $36.45 | filing |
| 16 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $124K3,331 at $37.26 | filing |
| 16 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $41811 at $37.96 | filing |
| 16 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $174K4,776 at $36.45 | filing |
| 16 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $124K3,331 at $37.26 | filing |
| 16 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $41811 at $37.96 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $77K2,147 at $36.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $189K5,103 at $36.99 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $37510 at $37.54 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $77K2,147 at $36.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $189K5,103 at $36.99 | filing |
News
No headline names them, or the companies they trade most, lately.